FR2357566B1 - - Google Patents

Info

Publication number
FR2357566B1
FR2357566B1 FR7720476A FR7720476A FR2357566B1 FR 2357566 B1 FR2357566 B1 FR 2357566B1 FR 7720476 A FR7720476 A FR 7720476A FR 7720476 A FR7720476 A FR 7720476A FR 2357566 B1 FR2357566 B1 FR 2357566B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7720476A
Other languages
French (fr)
Other versions
FR2357566A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Beecham Group PLC
Original Assignee
Beecham Group PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beecham Group PLC filed Critical Beecham Group PLC
Publication of FR2357566A1 publication Critical patent/FR2357566A1/fr
Application granted granted Critical
Publication of FR2357566B1 publication Critical patent/FR2357566B1/fr
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D499/00Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • A61K31/429Thiazoles condensed with heterocyclic ring systems
    • A61K31/43Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Cephalosporin Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
FR7720476A 1976-07-07 1977-07-04 Procede de preparation d'amoxycilline sodique Granted FR2357566A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB28179/76A GB1527557A (en) 1976-07-07 1976-07-07 Process for preparing solid sodium amoxycillin
CH836177A CH634847A5 (de) 1976-07-07 1978-01-01 Verfahren zur herstellung von festem natriumamoxycillin.

Publications (2)

Publication Number Publication Date
FR2357566A1 FR2357566A1 (fr) 1978-02-03
FR2357566B1 true FR2357566B1 (enExample) 1980-09-12

Family

ID=25703205

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7720476A Granted FR2357566A1 (fr) 1976-07-07 1977-07-04 Procede de preparation d'amoxycilline sodique

Country Status (9)

Country Link
US (1) US4222939A (enExample)
JP (1) JPS536415A (enExample)
BE (1) BE856446A (enExample)
CA (1) CA1075230A (enExample)
CH (1) CH634847A5 (enExample)
DE (1) DE2729112C2 (enExample)
FR (1) FR2357566A1 (enExample)
GB (1) GB1527557A (enExample)
NL (1) NL7707494A (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2503710B1 (fr) * 1981-04-10 1985-07-05 Bristol Myers Co Procede de production du sel de sodium de l'amoxicilline
EP0131147B2 (en) * 1983-06-10 1996-12-04 Beecham Group p.l.c. Crystalline amoxycillin salt
JPH0720971B2 (ja) * 1983-06-10 1995-03-08 ビーチャム・グループ・ピーエルシー 結晶性アモキシシリンナトリウム,その製法及びそれを含む医薬組成物
GB8608962D0 (en) * 1986-04-12 1986-05-14 Beecham Group Plc Beta-lactam antibiotics
CN117603157A (zh) * 2023-11-07 2024-02-27 桂林南药股份有限公司 阿莫西林胶囊杂质、制备方法、应用及其检测方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1241844A (en) * 1968-08-23 1971-08-04 Beecham Group Ltd Penicillins
BE789551A (fr) * 1971-10-01 1973-03-29 Unilever Emery Nouveaux composes organometalliques
GB1464026A (en) * 1974-09-25 1977-02-09 Beecham Group Ltd Preparation of beta-lactam antibiotics
GB1463563A (en) * 1974-10-10 1977-02-02 Beecham Group Ltd Pharmaceutical compositions

Also Published As

Publication number Publication date
DE2729112C2 (de) 1986-01-02
NL7707494A (nl) 1978-01-10
JPS536415A (en) 1978-01-20
CA1075230A (en) 1980-04-08
DE2729112A1 (de) 1978-01-12
GB1527557A (en) 1978-10-04
CH634847A5 (de) 1983-02-28
FR2357566A1 (fr) 1978-02-03
US4222939A (en) 1980-09-16
BE856446A (fr) 1978-01-04

Similar Documents

Publication Publication Date Title
JPS573375B2 (enExample)
DE2628832C3 (enExample)
DK162876A (enExample)
FR2357566B1 (enExample)
JPS5548671Y2 (enExample)
JPS558759Y2 (enExample)
DK142219C (enExample)
JPS5298091U (enExample)
JPS52134859U (enExample)
JPS52144281U (enExample)
DK136705C (enExample)
JPS5353198Y2 (enExample)
JPS5342646U (enExample)
JPS5364465U (enExample)
CS178368B1 (enExample)
JPS5297694U (enExample)
JPS5353649U (enExample)
JPS5325668U (enExample)
JPS536425U (enExample)
JPS5381295U (enExample)
DD126817A1 (enExample)
DD126321A1 (enExample)
CH606942A5 (enExample)
CH611223A5 (enExample)
CH612075A5 (enExample)

Legal Events

Date Code Title Description
ST Notification of lapse